Bernasconi Riccardo, Pertel Thomas, Luban Jeremy, Molinari Maurizio
Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland.
J Biol Chem. 2008 Jun 13;283(24):16446-54. doi: 10.1074/jbc.M802272200. Epub 2008 Apr 15.
Normally, non-native polypeptides are not transported through the secretory pathway. Rather, they are translocated from the endoplasmic reticulum (ER) lumen into the cytosol where they are degraded by proteasomes. Here we characterize the function in ER quality control of two proteins derived from alternative splicing of the OS-9 gene. OS-9.1 and OS-9.2 are ubiquitously expressed in human tissues and are amplified in tumors. They are transcriptionally induced upon activation of the Ire1/Xbp1 ER-stress pathway. OS-9 variants do not associate with folding-competent proteins. Rather, they selectively bind folding-defective ones thereby inhibiting transport of non-native conformers through the secretory pathway. The intralumenal level of OS-9.1 and OS-9.2 inversely correlates with the fraction of a folding-defective glycoprotein, the Null(hong kong) (NHK) variant of alpha1-antitrypsin that escapes retention-based ER quality control. OS-9 up-regulation does not affect NHK disposal, but reduction of the intralumenal level of OS-9.1 and OS-9.2 substantially delays disposal of this model substrate. OS-9.1 and OS-9.2 also associate transiently with non-glycosylated folding-defective proteins, but association is unproductive. Finally, OS-9 activity does not require an intact mannose 6-P homology domain. Thus, OS-9.1 and OS-9.2 play a dual role in mammalian ER quality control: first as crucial retention factors for misfolded conformers, and second as promoters of protein disposal from the ER lumen.
正常情况下,非天然多肽不会通过分泌途径运输。相反,它们会从内质网(ER)腔转运到细胞质中,并在那里被蛋白酶体降解。在此,我们描述了源自OS-9基因可变剪接的两种蛋白质在内质网质量控制中的功能。OS-9.1和OS-9.2在人体组织中普遍表达,并在肿瘤中扩增。它们在Ire1/Xbp1内质网应激途径激活后被转录诱导。OS-9变体不与具有折叠能力的蛋白质结合。相反,它们选择性地结合折叠缺陷的蛋白质,从而抑制非天然构象体通过分泌途径的运输。OS-9.1和OS-9.2的腔内水平与一种折叠缺陷糖蛋白α1-抗胰蛋白酶的Null(香港)(NHK)变体逃避基于滞留的内质网质量控制的比例呈负相关。OS-9的上调不影响NHK的处理,但降低OS-9.1和OS-9.2的腔内水平会显著延迟该模型底物的处理。OS-9.1和OS-9.2也会与非糖基化的折叠缺陷蛋白短暂结合,但这种结合没有效果。最后,OS-9的活性不需要完整的甘露糖6-磷酸同源结构域。因此,OS-9.1和OS-9.2在哺乳动物内质网质量控制中发挥双重作用:首先作为错误折叠构象体的关键滞留因子,其次作为促进内质网腔中蛋白质处理的因子。